e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Panel discussion on global burden of TB
R. Duarte (Porto, Portugal), C. Lange (Borstel, Germany), M. Raviglione (Geneva, Switzerland)
Source:
ERS webinar 2022: Panel discussion on global burden of TB
Number:
0
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Duarte (Porto, Portugal), C. Lange (Borstel, Germany), M. Raviglione (Geneva, Switzerland). Panel discussion on global burden of TB. ERS webinar 2022: Panel discussion on global burden of TB
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
DHEERESH KUMAR - 09.03.2022 05:31
thanks for sharing this discussion on global burden of TB
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Increased incidence of TB disease within the health-care workers in an intermediate TB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
The global response to rifampicin-resistant tuberculosis: Current situation and recent trends
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Home based tuberculosis (TB) care program
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Characteristics of tuberculosis (TB) in patients that died from TB in Poland
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Knowledge and attitude about tuberculosis disease in a health workers population
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
The global risk of dying from multidrug-resistant tuberculosis (MDR-TB)
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014
The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
MDR-TB treatment outcomes in HIV positive patients
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Prevalence of latent tuberculosis infection among household contacts and community controls in South India
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Tuberculosis (TB) in teenagers-an output of old / new national TB program
Source: Eur Respir J 2002; 20: Suppl. 38, 216s
Year: 2002
Tuberculosis (TB) in homeless population in Poland
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Four cases, one family: A cluster of resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Risk factors for acquired drug-resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Comparison of tuberculosis surveillance systems in low-incidence industrialised countries
Source: Eur Respir J 2008; 32: 1616-1624
Year: 2008
Trend in TB control in Republic of Moldova: High MDRTB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Source: Eur Respir J 2015; 46: 1563-1576
Year: 2015
Impact of social support programme on MDR-TB patients' treatment outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept